<DOC>
	<DOCNO>NCT00307515</DOCNO>
	<brief_summary>A comparison fibrin sealant 2 versus Surgicel® addition standard surgical practice stop mild moderate soft tissue bleed retroperitoneal intra-abdominal surgery .</brief_summary>
	<brief_title>Evaluation Fibrin Sealant 2 Retroperitoneal Intra-Abdominal Surgery</brief_title>
	<detailed_description>The time take stop bleeding measure compare patient treat fibrin sealant 2 treated Surgicel® .</detailed_description>
	<mesh_term>Blood Loss , Surgical</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>Male Female subject require nonemergent retroperitoneal intraabdominal surgical procedure Presence appropriate softtissue target bleed site ( challenge bleed site topical hemostatic adjunct might typically use ) identify intraoperatively surgeon Subjects must willing participate study provide write informed consent Subjects undergoing emergency surgery Parenchymal anastomotic bleeding site consider randomization Subjects intraoperative finding identify surgeon may preclude conduct study procedure Subjects know intolerance blood product one component study product Subjects unwilling receive blood product Subjects know autoimmune immunodeficiency disease ( include know HIV Subjects know , current alcohol and/or drug abuser Subjects participate another investigational drug device research study within 30 day enrollment Female subject pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>